Lilly Bounces Into ‘Sell in May’ Territory Amid Pricing Pressure
Eli Lilly posts above-consensus Q1 results, lifting shares yet leaving the year-to-date narrative pressured by pricin...
Eli Lilly posts above-consensus Q1 results, lifting shares yet leaving the year-to-date narrative pressured by pricin...
Tesla stock jumps about 19% in the past month, renewing the old Sell in May debate as summer trading looms and moment...